Since previous studies have reported that circadian genes including BMAL1 are reduced in almost cancers, we hypothesized that tumor hypoxia, a common and predominant occurrence in cancer, plays a critical role in decrease of the BMAL1 circadian gene. The gene discussed is BMAL1; the disease is cancer.